Providence St. Vincent renames pavilion for Nike co-founder Phil Knight
The Knights have given Providence $100 million since 2014, philanthropy that seeded a heart transplant program. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 13, 2021 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Providence St. Vincent renames pavilion for Phil and Penny Knight
The Knights have given Providence $100 million since 2014, philanthropy that seeded a heart transplant program. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 13, 2021 Category: Health Management Authors: Elizabeth Hayes Source Type: news

Tunisia: 'Number of Organ Donations Is Low Compared to Needs in Tunisia - CNPTO
[Tunis Afrique Presse] Tunis/Tunisia -- Director of the National Center for the Promotion of Organ Transplantation (French: CNPTO) Taieb Ben Abdallah said Thursday that the number of organ donations is low compared to demand in Tunisia, stating that the needs are estimated annually at 200 liver transplants, 50 heart transplants and 20 lung transplants. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 8, 2021 Category: African Health Source Type: news

Tucson maker of temporary artificial hearts acquired by California company
A Tucson medical technology company that is the only firm in the world with a federally approved temporary total artificial heart, has been acquired. SynCardia Systems LLC was purchased by California-based Picard Medical Inc., a portfolio company of Hunniwell Lake Ventures LLC, which specializes in making investments in medtech companies. Financial details of the deal were not made public. Picard said the acquisition will give SynCardia added technical and commercial expertise as well as access… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 5, 2021 Category: Pharmaceuticals Authors: Jeff Gifford Source Type: news

Tucson maker of temporary artificial hearts acquired by California company
A Tucson medical technology company that is the only firm in the world with a federally approved temporary total artificial heart, has been acquired. SynCardia Systems LLC was purchased by California-based Picard Medical Inc., a portfolio company of Hunniwell Lake Ventures LLC, which specializes in making investments in medtech companies. Financial details of the deal were not made public. Picard said the acquisition will give SynCardia added technical and commercial expertise as well as access… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 5, 2021 Category: Biotechnology Authors: Jeff Gifford Source Type: news

Why Can ’t I Get A COVID-19 Booster Shot If I’ve Been Vaccinated With Moderna or J & J?
There’s been quite a bit of news about COVID-19 booster shots lately, and it’s been more confusing than reassuring. Public health officials don’t agree on whether everyone needs a booster yet, and in the same way that the vaccines were rolled out to different groups of people one category at a time as government agencies reviewed studies to make sure they were safe and effective, boosters are being doled out to certain people first. Here’s where we stand for now. If the vaccines work, why do I need a booster? The three vaccines that are currently available in the U.S.—from Pfizer-BioNTech, Mod...
Source: TIME: Health - September 30, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Changes in Use of LVADs as BTT With New Heart Allocation Policy Changes in Use of LVADs as BTT With New Heart Allocation Policy
This study found that the number of patients with bridge to heart transplantation on the transplant list decreased dramatically after the allocation change from a 3-tiered system to a 6-tiered system.JACC: Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 24, 2021 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

FDA Panel Recommends Against Following White House Plan for Booster Doses for All
A U.S. Food and Drug Administration (FDA) committee voted unanimously Friday to recommend booster doses of Pfizer-BioNTech’s COVID-19 vaccine for those over age 65 and those at higher risk of exposure to the virus, including healthcare, frontline and essential workers, under emergency use authorization, but stopped short of recommending boosters for the general population. (Boosters have already been authorized for those with compromised immune systems.) Pfizer-BioNTech had originally requested that the FDA consider full approval of a booster dose for all people who have been vaccinated with its shot. The 18 members ...
Source: TIME: Health - September 18, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

COVID-19 Is Forcing Us to Talk About Rationing Health Care in the U.S. Again. Could We Have Avoided This?
On Sept. 7, the country’s leading COVID-19 doctor issued a dire warning about the growing number of pandemic cases in the country, and the shrinking number of ICU beds available to care for the sickest people. Speaking on CNN, Dr. Anthony Fauci, the chief White House medical advisor, said we are “perilously close in certain areas of the country of getting so close to having full occupancy that you’re going to be in a situation where you’re going to have to make some tough choices.” Those tough choices, he admitted, include discussions about whether scarce resources should go to people who have...
Source: TIME: Health - September 10, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Organ Transplant Activity Declined During 2020
The most affected organ transplants were kidney, followed by lung, liver, and heart (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - September 3, 2021 Category: Respiratory Medicine Tags: Cardiology, Gastroenterology, Nephrology, Pulmonology, Surgery, Conference News, Source Type: news

Heart transplant patient reunites with family who saved his life
Amanda Reynolds tragically lost her husband, David, in 2018. However, because he was an organ donor, his heart saved the life of another and now beats on in David "Spider" Shell. Reynolds and Shell reunited in February 2020, right before the pandemic. Learn more. The University of Kansas Health System is a premier academic health system providing full range of services, from routine primary care to advanced care for complex conditions. It includes The University of Kansas Physicians, the region’s… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 2, 2021 Category: Pharmaceuticals Authors: The University of Kansas Health System Source Type: news

NIDCR's Fall 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Fall 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   NIDCR News 5 Q&As About “Oral Health in America: Advances and Challenges” NIDCR issued a brief Q&A regarding details of the forthcoming report Oral Health in America: Advances and Challenges, which will be published in Fall 2021. This comprehensive report will examine improvements in oral health over t...
Source: NIDCR Science News - September 1, 2021 Category: Dentistry Source Type: news

What are Some of the Complications of Short Bowel Syndrome?
Discussion Necrotizing enterocolitis (NEC) is one of the most common gastrointestinal emergencies in neonates. Mortality rates are from 0-45% depending on infant weight and gestation with more premature and smaller infants having greater mortality. NEC usually occurs in premature infants but it also occurs in term infants. The etiology is unknown but is probably multifactorial with ischemia and/or reperfusion playing some role. There are ‘outbreaks’ of NEC but no causative organism has been identified. Regardless of the originating cause, inflammation of the intestine and release of inflammatory mediators cause...
Source: PediatricEducation.org - August 30, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

UK's oldest living heart transplant patient marks 90th birthday
Ted Warner was only expected to live for eight more years after his operation in 1990. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 28, 2021 Category: Consumer Health News Source Type: news

AHA News: Despite Progress, Black Patients Still Less Likely to Get Heart Transplants
WEDNESDAY, Aug. 25, 2021 (American Heart Association News) -- Black people in need of a new heart are less likely than their white peers to get a transplant, and when they do, they're more likely to die afterward, according to new research. The... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 25, 2021 Category: General Medicine Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) e...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

UW Medicine DENIES life-saving heart transplant to patient because he won’t take heart-damaging COVID vaccines
(Natural News) After a year and half of refusing efficacious treatment to COVID patients, the University of Washington Medical Center refuses to perform life-saving operations if the patient is not vaccinated with COVID spike proteins. UW Medicine is currently denying a 64-year-old patient a life-saving heart transplant because he won’t take the experimental vaccine protocol.... (Source: NaturalNews.com)
Source: NaturalNews.com - August 20, 2021 Category: Consumer Health News Source Type: news

American Agriculture Almost Ruined My Little English Farm. Now I ’m Trying to Save It
For much of my early life America meant progress, the bright shining farming future. I was a kid on an old-fashioned farm in the North of England, and we were way off the pace of change. We had tractors and small machinery, of course, but horse tack still hung from the beams in the barn, gathering dust, and all of my grandfather’s stories were about working horses. Ours was a mixed farm of different animals and crops, the kind of farm that existed everywhere until a few decades ago. It was all crooked little fields, no two looking the same, and every kind of farm animal and crop that would grow on it, all swirling ro...
Source: TIME: Health - August 5, 2021 Category: Consumer Health News Authors: James Rebanks Tags: Uncategorized Sustainability TIME 2030 Source Type: news

Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart
- Ultreon ™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence (Source: Abbott.com)
Source: Abbott.com - August 3, 2021 Category: Pharmaceuticals Source Type: news

Abbott receives FDA clearance for AI-powered heart imaging software
Abbott has received clearance from the FDA  for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels. (Source: mobihealthnews)
Source: mobihealthnews - August 3, 2021 Category: Information Technology Source Type: news

Hearts From Drug Abusers Can Be Used for Transplants
THURSDAY, July 29, 2021 -- In a finding that could mean more patients desperate for a heart transplant get a new lease on life, two new studies show that hearts from donors who abused drugs can be safely donated. In the past two decades, the U.S.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 29, 2021 Category: General Medicine Source Type: news

Hearts From Drug Abusers Can Be Used for Transplants
Title: Hearts From Drug Abusers Can Be Used for TransplantsCategory: Health NewsCreated: 7/29/2021 12:00:00 AMLast Editorial Review: 7/29/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 29, 2021 Category: Cardiology Source Type: news

Donor Drug Use Not Tied to Survival for Heart Transplant Recipients
WEDNESDAY, July 28, 2021 -- Toxicological evidence of drug use for donors accepted for heart transplantation is not associated with recipient survival, and overall recipient survival continues to improve, according to two studies published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 28, 2021 Category: Pharmaceuticals Source Type: news

Hearts from donors who died of drug overdoses ARE safe to use in transplant surgeries, studies find
Two new studies from the American Heart Association suggest that hearts from donors who died of drug overdoses are safe to transplant into patients who need them. (Source: the Mail online | Health)
Source: the Mail online | Health - July 28, 2021 Category: Consumer Health News Source Type: news

Cardio-cerebrovascular disease history complicates hematopoietic cell transplant outcomes
(Cactus Communications) Transplanting hematopoietic stem cells to treat cancers and other conditions carries with it the risk of developing cardio-cerebrovascular diseases (CCVD)--disorders affecting the blood vessels of the heart and brain. Although research on post-transplant CCVD is extensive, there is paucity of knowledge on the effects of pre-transplant CCVD on transplant outcomes. Now researchers in China suggest pre-transplant CCVD indirectly affects patient mortality and survival following transplant through their strong association with post-transplant CCVD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

AI model identifies SARS-CoV-2 from blood tests, chest x-rays
An artificial intelligence (AI) model that analyzed data from blood tests an...Read more on AuntMinnie.comRelated Reading: Vuno inks deal with Samsung integrating AI with mobile x-ray AI may predict heart disease risk on chest x-ray Chest x-ray may predict risk of hospitalization in COVID-19 AI of x-ray predicts prognosis of COVID-19 patients Daily chest x-rays not needed in COVID-19 patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 16, 2021 Category: Radiology Source Type: news

Death disruptor: how an Australian funnel-web spider may help human hearts
University of Queensland researchers are investigating if protein in venom of Fraser Island spider can stop cardiac cells dyingA protein in the venom of adeadly Australian funnel-web spider may be able to reduce cardiac damage from heart attacks and extend the life of donor hearts used in transplants, according to new research.Venom from the Fraser Island funnel-web, named for the south-east Queensland island where it is found, contains aprotein known as Hi1a.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 15, 2021 Category: Science Authors: Donna Lu Tags: Heart disease Science Medical research Australia news Queensland Source Type: news

AHA News: Genetic Problem Led to a Heart Transplant at 24. Her New Heart Has a Genetic Problem, Too.
WEDNESDAY, July 14, 2021 (American Heart Association News) -- At 13, Leilani Graham was running on the treadmill in her garage when she suddenly collapsed. Her mother, who was supposed to be gone, heard a bizarre moaning sound coming from the garage... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 14, 2021 Category: General Medicine Source Type: news

AHA News: Genetic Problem Led to a Heart Transplant at 24. Her New Heart Has a Genetic Problem, Too.
Title: AHA News: Genetic Problem Led to a Heart Transplant at 24. Her New Heart Has a Genetic Problem, Too.Category: Health NewsCreated: 7/14/2021 12:00:00 AMLast Editorial Review: 7/14/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 14, 2021 Category: Cardiology Source Type: news

RSIP Vision launches MRI segmentation software
Computer software and artificial intelligence company RSIP Vision has release...Read more on AuntMinnie.comRelated Reading: RSIP Vision debuts prostate AI registration tool RSIP releases new CT segmentation software for orthopedics RSIP Vision launches coronary artery tool RSIP Vision unveils AI-based image segmentation tool RSIP Vision launches new heart POC ultrasound (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 12, 2021 Category: Radiology Source Type: news

Mayo Clinic Minute: Why bone marrow donor diversity is needed
Bone marrow transplants are procedures that infuse healthy blood stem cells into your body to replace damaged or diseased bone marrow. Just like people in need of solid organ transplants, such as hearts or kidneys, people in need of a bone marrow transplant have to find a matching donor. Dr. Ernesto Ayala, a Mayo Clinic hematologist and oncologist, says bone marrow donations from people of all races and ethnicities are essential in order to help… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 8, 2021 Category: Databases & Libraries Source Type: news

What Problems are Ciliopathies Associated With?
Discussion Nephronophthisis (NPHP) one cause of end-stage renal disease (ESRD) usually occurring before age 30 years. NPHP is a non-motile ciliopathy affecting cellular sensing in the renal tubular epithelium. See To Learn More below. The incidence varies according to location with 1:1 million in the US but 1:50,000 in Finland. There are 3 subtypes: Infantile Occurs usually within 1 year of life Enlarged kidneys and severe hypertension In utero can have oligohydramnios problems such as pulmonary hypoplasia, facial dysmorphisms, limb contractures Extra-renal problems include congenital heart disease, liver fibrosis, recur...
Source: PediatricEducation.org - July 5, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

TJ Olsen rings bell and goes home after successful heart transplant
Bells ringing, drums pounding, and hearts singing. After a successful heart transplant, TJ Olsen, son of former Carolina Panther Greg Olsen and Kara Olsen, went home. There is simply no greater feeling than seeing a happy, healthy patient go home with their family. Learn more about Atrium Health Levine Children’s pediatric heart surgery and cardiology program. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 2, 2021 Category: Pharmaceuticals Authors: Atrium Health Source Type: news

NIDCR's Summer 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Summer 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR to Release Report on Oral Health in America As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions...
Source: NIDCR Science News - July 1, 2021 Category: Dentistry Source Type: news

For transplant patients, COVID-19 vaccination presents a different uncertainty
(University of California - San Diego) Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Pumped to assist the heart with an artificial aorta
(Ecole Polytechnique F é d é rale de Lausanne) Scientists from EPFL and University of Bern have successfully implanted - in vivo - their first artificial tubular muscle that augments the aorta and assists cardiac function in pumping blood. Based on these results, the Werner Siemens Foundation has provided the green-light for granting an extra 8 million CHF over 8 years to develop artificial muscles for human disorders. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 30, 2021 Category: International Medicine & Public Health Source Type: news

WHO guidance on Artificial Intelligence  to improve healthcare, mitigate risks worldwide 
Artificial Intelligence (AI) holds “enormous potential” for improving the health of millions around the world if ethics and human rights are at the heart of its design, deployment, and use, the head of the UN health agency said on Monday.  (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - June 28, 2021 Category: International Medicine & Public Health Source Type: news

What Types of New Therapies are Available for Cystic Fibrosis?
Discussion Cystic fibrosis (CF) was identified in 1938 by Dr. Dorothy Andersen who described 49 patients with pancreatic insufficiency. Since that time significant achievements in the knowledge about the disease and treatments for patients have changed the mortality from a few months to patients living into middle adulthood or even later. Quality of life for patients and their families and friends has also markedly improved. CF is the classic Mendelian autosomal recessive genetic disorder which is a worldwide disorder but affects people of north European ancestry more often where the main mutation is more common. There are...
Source: PediatricEducation.org - June 28, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Elderly Heart Transplant Patients Have 5-Year Survival Similar to Younger Recipients Elderly Heart Transplant Patients Have 5-Year Survival Similar to Younger Recipients
Survival of elderly heart transplant recipients at 5 years is similar to that of younger recipients even though older adults are more likely to get organs from higher-risk donors, a recent study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 24, 2021 Category: Consumer Health News Tags: Transplantation News Source Type: news

Providence Heart Institute receives key approval for heart transplants
"It ’s the end of the beginning" for the transplant program. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 23, 2021 Category: American Health Authors: Elizabeth Hayes Source Type: news

Providence Heart Institute receives key approval for heart transplants
"It ’s the end of the beginning" for the transplant program. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 23, 2021 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Janssen Submits New Drug Application to U.S. FDA for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, June 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of XARELTO® (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients aged birth to less than 18 years of age after at least five days of initial parenteral anticoagulant treatment; and thromboprophylaxis (prevention of blood clots) in patients aged 2 years and older with co...
Source: Johnson and Johnson - June 23, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: At 17, He Received a New Heart. By 23, He Began Transitioning.
FRIDAY, June 18, 2021 (American Heart Association News) -- For most transgender people, starting hormone therapy requires a therapist's approval. As the recipient of a new heart, Maddox Jones also needed his transplant team's OK. " It was a long and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 18, 2021 Category: General Medicine Source Type: news

New artificial heart shows promising results in 'auto-mode' -- initial clinical experience reported in ASAIO Journal
(Wolters Kluwer Health) An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the ASAIO Journal, official journal of the American Society for Artificial Internal Organs. The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 18, 2021 Category: International Medicine & Public Health Source Type: news

Rapid exclusion of COVID-19 infection using AI, EKG technology
(Mayo Clinic) Artificial intelligence (AI) may offer a way to accurately determine that a person is not infected with COVID-19. An international retrospective study finds that infection with SARS-CoV-2, the virus that causes COVID-19, creates subtle electrical changes in the heart. An AI-enhanced EKG can detect these changes and potentially be used as a rapid, reliable COVID-19 screening test to rule out COVID-19 infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 15, 2021 Category: Infectious Diseases Source Type: news

Rapid exclusion of COVID-19 infection using AI, EKG technology
ROCHESTER, Minn. -- Artificial intelligence (AI) may offer a way to accurately determine that a person is not infected with COVID-19. An international retrospective study finds that infection with SARS-CoV-2, the virus that causes COVID-19, creates subtle electrical changes in the heart. An AI-enhanced EKG can detect these changes and potentially be used as a [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - June 15, 2021 Category: Hospital Management Source Type: news

AI analysis of SPECT MPI scans can predict future cardiac events
The combination of artificial intelligence (AI) and SPECT myocardial perfusio...Read more on AuntMinnie.comRelated Reading: Machine learning plus CT boosts prediction of major coronary events Report charts 80% drop in cardiac SPECT during COVID-19 Machine-learning model predicts adverse cardiac outcomes AI predicts heart attack, stroke on cardiac MRI Deep learning advances SPECT MPI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 12, 2021 Category: Radiology Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefin...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Old Age No Bar to Successful Heart Transplant, Study Finds
FRIDAY, June 11, 2021 -- People over 70 are far less likely to be considered for or to receive a new heart -- even though new research suggests their survival rates after transplant are similar to those of younger patients. For the study, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 11, 2021 Category: General Medicine Source Type: news